China Resources Pharma Shares Slump Over 5% Following Mixed Q1 Results From Subsidiaries

Stock News04-27 11:20

CHINARES PHARMA (03320) saw its shares decline more than 5% during the morning trading session. As of the time of writing, the stock was down 5.54%, trading at HK$5.46, with a turnover of HK$89.606 million. The movement follows the release of first-quarter financial results by several of its listed pharmaceutical subsidiaries. Among them, China Resources Sanjiu reported a 15.29% year-on-year decrease in its first-quarter net profit attributable to shareholders. Tasly Pharmaceutical Group posted a net profit of 370 million yuan, representing a 17.8% increase from the same period last year. Dong-E-E-Jiao announced a net profit of 455 million yuan, up 7.14% year-on-year. Notably, Kpc Pharmaceuticals,Inc. (600422) reported first-quarter revenue of 836 million yuan, a sharp decline of 48.01% year-on-year, falling back to levels seen a decade ago. The company recorded a net loss attributable to shareholders of 142 million yuan, marking its first first-quarter loss in two decades.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment